Fill in the form below and our experts will get back to you within 1 business day.
Accelerate your bioprocess development with comprehensive strain and cell line engineering solutions. From microbial chassis optimization to mammalian cell line development, we deliver high-performance production strains tailored to your needs.
Trusted by leading research and pharmaceutical institutions
E. coli, Bacillus, Yeast, Pichia
CHO, HEK293, Hybridoma
High-yield pathway optimization
From gene to production-ready strain, our comprehensive development services accelerate your bioprocess from concept to commercialization.
Comprehensive engineering services for E. coli, Bacillus, yeast, and other microbial hosts.
High-performance CHO and HEK293 cell line development for recombinant protein production.
Pathway optimization and flux engineering for high-yield bioproduct synthesis.
Process optimization for scalable fermentation from shake flask to bioreactor.
Non-rational optimization for stress tolerance through laboratory evolution and genome analysis.
GMP-compliant cell banking and comprehensive quality control services.
Our development team will help you achieve your titer and quality targets.
State-of-the-art strain development technologies for optimal production outcomes.
Our microbial platform combines CRISPR-based genome editing with high-throughput screening and systems biology approaches to develop high-performance production strains.
Precision genome modifications
Adaptive laboratory evolution
Error-prone PCR, UV, chemical
Genome-scale metabolic models
Host Options
CHO Platforms
Our mammalian platform delivers high-titer, stable CHO cell lines with optimized glycosylation profiles for therapeutic protein production.
Validated selection systems
Automated clone selection
Tailored glycosylation profiles
Systems metabolic engineering for optimal flux distribution and high-yield product synthesis.
Machine learning models guide strain optimization for improved productivity and robustness.
Detailed specifications for our strain and cell development services.
CRISPR-Cas9
TALEN/ZFN
Random Mutagenesis
Adaptive Evolution
Extended passage testing
PCR and culture methods
Multiple bioreactor scales
From initial assessment to production-ready strain, our streamlined workflow ensures efficient development.
Project assessment and host selection based on your product and process requirements.
Strain construction and engineering using advanced genetic tools and screening platforms.
Process optimization and scale-up for target titer, yield, and productivity.
Cell banking and comprehensive documentation for regulatory compliance.
Our strain development services support diverse industrial applications.
Antibodies, enzymes, hormones, and other recombinant proteins for pharmaceutical applications.
Organic acids, amino acids, vitamins, and other biochemicals for industrial applications.
Ethanol, butanol, biodiesel precursors, and other biofuel-related compounds.
Biodegradable plastics, polymers, and other materials from renewable sources.
Flavonoids, terpenoids, alkaloids, and other secondary metabolites.
Industrial enzymes for food, feed, textile, and detergent applications.
"They delivered an E. coli strain that exceeded our titer targets by 300%. The AI-assisted optimization really made a difference in our development timeline."
Biotech Company
Strain Development Team
"Our CHO cell line development project was completed ahead of schedule with exceptional productivity. The regulatory documentation was thorough and complete."
Pharmaceutical Company
Cell Line Development
"The Pichia engineering team developed a strain with significantly improved protein secretion. The fermentation optimization support was excellent."
Dr. Maria Peters
Roche
Multiple authors. Microorganisms. 2023
Comprehensive review of systems metabolic engineering strategies for industrial strain development.
View PublicationPMC9769770. Appl Environ Microbiol. 2022
Combining pathway engineering with adaptive evolution for efficient L-lactic acid production.
View PublicationWu Z et al. PNAS. 2025
Novel approach linking cellular lifespan engineering with improved chemical biosynthesis.
View PublicationReview in Biotechnology Advances. 2021
Comprehensive review of technologies for CHO cell line development and protein expression.
View PublicationReview in Microbial Cell Factories. 2022
Strategies for high-level recombinant protein production in E. coli systems.
View PublicationReview in Metabolic Engineering. 2023
Recent advances in metabolic engineering for organic acid production.
View PublicationFind answers to common questions about our strain development services.
Get a customized quote for your Strain and Cell Development Services project. Our experts will respond within 24 hours.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.